EDN1 and endothelial dysfunction: Assessing endothelial function often involves gauging plasma concentrations of ET-1, a peptide associated with vasoconstriction, and NO, a bioproduct linked with vasorelaxation [69], as an imbalance between these two molecules generally suggests endothelial dysfunction [70].